Assessing the interactions between radiotherapy and antitumour immunity

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989 · see citing works

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774 · see citing works

Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion

Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474 · see citing works

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

Motzer, R. J., Escudier, B., McDermott, D. F., George, S., Hammers, H. J., Srinivas, S., Tykodi, S. S., Sosman, J. A., Procopio, G., Plimack, E. R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1510665 · Cited by 5,807 · see citing works

Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025 · see citing works

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

Rittmeyer, A., Barlési, F., Waterkamp, D., Park, K., Ciardiello, F., von Pawel, J., Gadgeel, S. M., Hida, T., Kowalski, D. M., Cobo, M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)32517-x · Cited by 4,684 · see citing works

Innate and adaptive immune cells in the tumor microenvironment

Gajewski, T. F., Schreiber, H., & Fu, Y.-X. (2013) · Nature Immunology · doi:10.1038/ni.2703 · Cited by 4,148 · see citing works

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

Antonia, S. J., Villegas, A., Daniel, D., Vicente, D., Murakami, S., Hui, R., Kurata, T., Chiappori, A., Lee, K. H., de Wit, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1809697 · Cited by 2,798 · see citing works

Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy

Topalian, S. L., Taube, J. M., Anders, R. A., & Pardoll, D. M. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.36 · Cited by 2,733 · see citing works

Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer

Twyman-Saint Victor, C., Rech, A. J., Maity, A., Rengan, R., Pauken, K. E., Stelekati, E., Benci, J. L., Xu, B., Dada, H., Odorizzi, P. M., et al. (2015) · Nature · doi:10.1038/nature14292 · Cited by 2,434 · see citing works

Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab

Riaz, N., Havel, J. J., Makarov, V., Desrichard, A., Urba, W. J., Sims, J. S., Hodi, F. S., Martín-Algarra, S., Mandal, R., Sharfman, W. H., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.028 · Cited by 2,401 · see citing works

Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma

Postow, M. A., Callahan, M. K., Barker, C. A., Yamada, Y. J., Yuan, J. D., Kitano, S., Mu, Z., Rasalan, T. S., Adamow, M. J., Ritter, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112824 · Cited by 2,087 · see citing works

DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity

Vanpouille-Box, C., Alard, A., Aryankalayil, M. J., Sarfraz, Y., Diamond, J. M., Schneider, R. J., Inghirami, G., Coleman, C. N., Formenti, S. C., & Demaria, S. (2017) · Nature Communications · doi:10.1038/ncomms15618 · Cited by 1,834 · see citing works

Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 Antibody

Dewan, M. Z., Galloway, A. E., Kawashima, N., Dewyngaert, J. K., Babb, J. S., Formenti, S. C., & Demaria, S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0265 · Cited by 1,678 · see citing works

Biomarkers in Cancer Staging, Prognosis and Treatment Selection

Ludwig, J. A., & Weinstein, J. N. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1739 · Cited by 1,655 · see citing works

Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature

Gupta, D., & Lis, C. G. (2010) · Nutrition Journal · doi:10.1186/1475-2891-9-69 · Cited by 1,485 · see citing works

The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer

McMillan, D. C. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.08.003 · Cited by 1,409 · see citing works

Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated

Demaria, S., Ng, B., Devitt, M. L., Babb, J. S., Kawashima, N., Liebes, L., & Formenti, S. C. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.09.012 · Cited by 1,393 · see citing works

TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance

Thomas, D. A., & Massagué, J. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.012 · Cited by 1,355 · see citing works

Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade

Dovedi, S. J., Adlard, A. L., Lipowska‐Bhalla, G., McKenna, C., Jones, S., Cheadle, E. J., Stratford, I. J., Poon, E., Morrow, M., Stewart, R. A., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1258 · Cited by 1,316 · see citing works

Regional Nodal Irradiation in Early-Stage Breast Cancer

Whelan, T. J., Olivotto, I. A., Parulekar, W. R., Ackerman, I., Chua, B. H., Nabid, A., Vallis, K. A., White, J. R., Rousseau, P., Fortin, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1415340 · Cited by 1,299 · see citing works

Using immunotherapy to boost the abscopal effect

Ngwa, W., Irabor, O. C., Schoenfeld, J. D., Hesser, J., Demaria, S., & Formenti, S. C. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2018.6 · Cited by 1,260 · see citing works

A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study

Sun, R., Limkin, E. J., Vakalopoulou, M., Dercle, L., Champiat, S., Han, S. R., Verlingue, L., Brandao, D., Lancia, A., Ammari, S., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30413-3 · Cited by 1,236 · see citing works

Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial.

Shaverdian, N., Lisberg, A. E., Bornazyan, K., Veruttipong, D., Goldman, J. W., Formenti, S. C., Garon, E. B., & Lee, P. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30380-7 · Cited by 1,091 · see citing works

Lost in translation: animal models and clinical trials in cancer treatment.

(2014) · Europe PMC (PubMed Central) · Cited by 1,033 · see citing works

Immune-Mediated Inhibition of Metastases after Treatment with Local Radiation and CTLA-4 Blockade in a Mouse Model of Breast Cancer

Demaria, S., Kawashima, N., Yang, A. M., Devitt, M. L., Babb, J. S., Allison, J. P., & Formenti, S. C. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.728.11.2 · Cited by 1,016 · see citing works

Radiotherapy induces responses of lung cancer to CTLA-4 blockade

Formenti, S. C., Rudqvist, N.-P., Golden, E., Cooper, B., Wennerberg, E., Lhuillier, C., Vanpouille-Box, C., Friedman, K., Ferrari de Andrade, L., Wucherpfennig, K. W., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0232-2 · Cited by 928 · see citing works

Pseudoprogression and Immune-Related Response in Solid Tumors

Chiou, V. L., & Burotto, M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.6870 · Cited by 898 · see citing works

Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)

Horn, L., Spigel, D. R., Vokes, E. E., Holgado, E., Ready, N., Steins, M. B., Poddubskaya, E. V., Borghaei, H., Felip, E., Paz-Ares, L. G., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.3062 · Cited by 861 · see citing works

Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung Cancer

McLaughlin, J. F., Han, G., Schalper, K. A., Carvajal‐Hausdorf, D., Pelekanou, V., Rehman, J., Velcheti, V., Herbst, R. S., LoRusso, P. M., & Rimm, D. L. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.3638 · Cited by 835 · see citing works

Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy

de Vries, I. J. M., Lesterhuis, W. J., Barentsz, J. O., Verdijk, P., van Krieken, J. H., Boerman, O. C., Oyen, W. J. G., Bonenkamp, J. J., Boezeman, J. B., Adema, G. J., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1154 · Cited by 821 · see citing works

Identification of prognostic factors in patients with brain metastases: a review of 1292 patients

Lagerwaard, F. J., Levendag, P. C., Nowak, P. J. C. M., Eijkenboom, W. H., Hanssens, P. E. J., & Schmitz, P. I. M. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00442-8 · Cited by 721 · see citing works

Immunity, inflammation, and cancer: an eternal fight between good and evil

Shalapour, S., & Karin, M. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80007 · Cited by 703 · see citing works

The mathematics of cancer: integrating quantitative models

Altrock, P. M., Liu, L. L., & Michor, F. (2015) · Nature reviews. Cancer · doi:10.1038/nrc4029 · Cited by 685 · see citing works

Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial

Golden, E. B., Chhabra, A. M., Chachoua, A., Adams, S., Donach, M. E., Fenton-Kerimian, M., Friedman, K. P., Ponzo, F., Babb, J. S., Goldberg, J. D., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00054-6 · Cited by 671 · see citing works

A Validated Mathematical Model of Cell-Mediated Immune Response to Tumor Growth

de Pillis, L. G., Radunskaya, A., & Wiseman, C. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0564 · Cited by 656 · see citing works

Standardizing methods to address clonality in population studies

Arnaud‐Haond, S., Duarte, C. M., Alberto, F., & Serrão, E. Á. (2007) · Molecular Ecology · doi:10.1111/j.1365-294x.2007.03535.x · Cited by 654 · see citing works

21 years of Biologically Effective Dose

Fowler, J. F. (2010) · British Journal of Radiology · doi:10.1259/bjr/31372149 · Cited by 643 · see citing works

Novel cancer immunotherapy agents with survival benefit: recent successes and next steps

Sharma, P., Wagner, K., Wolchok, J. D., & Allison, J. P. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3153 · Cited by 639 · see citing works

Classical Mathematical Models for Description and Prediction of Experimental Tumor Growth

Benzekry, S., Lamont, C., Beheshti, A., Tracz, A., Ebos, J. M. L., Hlatky, L., & Hahnfeldt, P. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003800 · Cited by 586 · see citing works

Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and Temozolomide

Grossman, S. A., Ye, X., Lesser, G. J., Sloan, A. E., Carraway, H. E., Desideri, S., & Piantadosi, S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0774 · Cited by 574 · see citing works

Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis

Shen, X., & Zhao, B. (2018) · BMJ · doi:10.1136/bmj.k3529 · Cited by 559 · see citing works

Systematic review of case reports on the abscopal effect

Abuodeh, Y. A., Venkat, P. S., & Kim, S. (2015) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2015.10.001 · Cited by 534 · see citing works

Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study

Willett, C. G., Duda, D. G., di Tomaso, E., Boucher, Y., Ancukiewicz, M., Sahani, D. V., Lahdenranta, J., Chung, D. C., Fischman, A. J., Lauwers, G. Y., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.1771 · Cited by 509 · see citing works

Positron Emission Tomography/Computed Tomography for Diagnosis of Prosthetic Valve Endocarditis

Saby, L., Laas, O., Habib, G., Cammilleri, S., Mancini, J., Tessonnier, L., Casalta, J., Gouriet, F., Ribéri, A., Aviérinos, J.-F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.092 · Cited by 503 · see citing works

Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8+ T cells

Carretero, R., Sektioglu, I. M., Garbi, N., Salgado, O. C., Beckhove, P., & Hämmerling, G. J. (2015) · Nature Immunology · doi:10.1038/ni.3159 · Cited by 501 · see citing works

Charged-particle therapy in cancer: clinical uses and future perspectives

Durante, M., Orecchia, R., & Loeffler, J. S. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.30 · Cited by 491 · see citing works

FDG PET of Infection and Inflammation

Love, C., Tomas, M. B., Tronco, G. G., & Palestro, C. J. (2005) · Radiographics · doi:10.1148/rg.255045122 · Cited by 484 · see citing works

Acquired resistance to immunotherapy and future challenges

Restifo, N. P., Smyth, M. J., & Snyder, A. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.2 · Cited by 463 · see citing works

Detection of Atherosclerotic Inflammation by 68 Ga-DOTATATE PET Compared to [ 18 F]FDG PET Imaging

Tarkin, J. M., Joshi, F. R., Evans, N. R., Chowdhury, M. M., Figg, N. L., Shah, A. V., Starks, L. T., Garrido, A. M., Manavaki, R., Yu, E., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.01.060 · Cited by 445 · see citing works

Interactions Between the Immune System and Cancer: A Brief Review of Non-spatial Mathematical Models

Eftimie, R., Bramson, J. L., & Earn, D. J. D. (2010) · Bulletin of Mathematical Biology · doi:10.1007/s11538-010-9526-3 · Cited by 436 · see citing works

18Fluorodeoxyglucose Positron Emission Tomography Imaging of Atherosclerotic Plaque Inflammation Is Highly Reproducible

Rudd, J. H. F., Myers, K. S., Bansilal, S., Macháč, J., Rafique, A., Farkouh, M. E., Fuster, V., & Fayad, Z. A. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.05.024 · Cited by 423 · see citing works

The Abscopal Effect Associated With a Systemic Anti-melanoma Immune Response

Stamell, E. F., Wolchok, J. D., Gnjatic, S., Lee, N. Y., & Brownell, I. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.03.017 · Cited by 387 · see citing works

Overlap and Effective Size of the Human CD8 + T Cell Receptor Repertoire

Robins, H. S., Srivastava, S. K., Campregher, P. V., Turtle, C. J., Andriesen, J. G., Riddell, S. R., Carlson, C. S., & Warren, E. H. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001442 · Cited by 383 · see citing works

Improved Survival with T Cell Clonotype Stability After Anti–CTLA-4 Treatment in Cancer Patients

Cha, E., Klinger, M., Hou, Y., Cummings, C., Ribas, A., Faham, M., & Fong, L. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008211 · Cited by 383 · see citing works

The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors

Tang, J., Yu, J. X., Hubbard-Lucey, V. M., Neftelinov, S. T., Hodge, J. P., & Lin, Y. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.210 · Cited by 382 · see citing works

PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival

Lipson, E. J., Vincent, J. G., Loyo, M., Kagohara, L. T., Luber, B. S., Wang, H., Xu, H., Nayar, S. K., Wang, T. S., Sidransky, D., et al. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0034 · Cited by 377 · see citing works

Lymphopenia Association With Gross Tumor Volume and Lung V5 and Its Effects on Non-Small Cell Lung Cancer Patient Outcomes

Tang, C. Z., Liao, Z. X., Gomez, D. R., Levy, L. B., Zhuang, Y., Gebremichael, R. A., Hong, D. S., Komaki, R. U., & Welsh, J. W. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.04.025 · Cited by 375 · see citing works

Forum: On Resisting Resistance

Brown, M. F. (1996) · American Anthropologist · doi:10.1525/aa.1996.98.4.02a00030 · Cited by 367 · see citing works

Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy

Marciscano, A. E. E., Ghasemzadeh, A., Nirschl, T. R., Theodros, D., Kochel, C. M., Francica, B. J., Muroyama, Y., Anders, R. A., Sharabi, A. B., Velarde, E., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3427 · Cited by 342 · see citing works

Radiation as an immunological adjuvant: current evidence on dose and fractionation

Demaria, S., & Formenti, S. C. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00153 · Cited by 333 · see citing works

Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy

Young, K. H., Baird, J. R., Savage, T., Cottam, B., Friedman, D. J., Bambina, S., Messenheimer, D. J., Fox, B. A., Newell, P., Bahjat, K. S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157164 · Cited by 327 · see citing works

Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells

Tang, C. Z., Welsh, J. W., de Groot, P. M., Massarelli, E., Chang, J. Y., Hess, K. R., Basu, S., Curran, M. A., Cabanillas, M. E., Subbiah, V., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1432 · Cited by 324 · see citing works

Radiation induces proinflammatory dysbiosis: transmission of inflammatory susceptibility by host cytokine induction

Gerassy-Vainberg, S., Blatt, A., Danin‐Poleg, Y., Gershovich, K., Sabo, E., Nevelsky, A., Daniel, S., Dahan, A., Ziv, O., Dheer, R., et al. (2017) · Gut · doi:10.1136/gutjnl-2017-313789 · Cited by 321 · see citing works

Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers

Derks, S., Liao, X., Chiaravalli, A. M., Xu, X., Camargo, M. C., Solcia, E., Sessa, F., Fleitas, T., Freeman, G. J., Rodig, S. J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9076 · Cited by 308 · see citing works

Tumor Irradiation Increases the Recruitment of Circulating Mesenchymal Stem Cells into the Tumor Microenvironment

Klopp, A. H., Spaeth, E. L., Dembinski, J. L., Woodward, W. A., Munshi, A., Meyn, R. E., Cox, J. D., Andreeff, M., & Marini, F. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1406 · Cited by 304 · see citing works

MRI of Tumor-Associated Macrophages with Clinically Applicable Iron Oxide Nanoparticles

Daldrup-Link, H. E., Golovko, D. M., Ruffell, B., DeNardo, D. G., Castaneda, R., Ansari, C., Rao, J., Tikhomirov, G. A., Wendland, M. F., Corot, C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3420 · Cited by 302 · see citing works

The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis

Dolan, R. D., Lim, J. E. K., McSorley, S. T., Horgan, P. G., & McMillan, D. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-16955-5 · Cited by 300 · see citing works

Safety of combining radiotherapy with immune-checkpoint inhibition

Hwang, W. L., Pike, L., Royce, T. J., Mahal, B. A. V., & Loeffler, J. S. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0046-7 · Cited by 298 · see citing works

The Model Muddle: In Search of Tumor Growth Laws

Gerlee, P. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4355 · Cited by 288 · see citing works

Usefulness of Fluorine-18 Positron Emission Tomography/Computed Tomography for Identification of Cardiovascular Implantable Electronic Device Infections

SARRAZIN, J., Philippon, F., Tessier, M., Guimond, J. V., Molin, F., Champagne, J., Nault, I., Blier, L. E., Nadeau, M., Charbonneau, L., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.11.059 · Cited by 284 · see citing works

Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease.

FUKS, Z. Y., Strober, S., Bobrove, A. M., Sasazuki, T., McMichael, A. J., & Kaplan, H. S. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108532 · Cited by 272 · see citing works

Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?

Neuwelt, E. A., Hamilton, B. E., Varallyay, C. G., Rooney, W. R., Edelman, R. D., Jacobs, P. M., & Watnick, S. G. (2009) · Kidney International · doi:10.1038/ki.2008.496 · Cited by 267 · see citing works

Imaging of Inflamed and Vulnerable Plaque in Coronary Arteries with 18F-FDG PET/CT in Patients with Suppression of Myocardial Uptake Using a Low-Carbohydrate, High-Fat Preparation

Wykrzykowska, J. J., Lehman, S., Williams, G., Parker, J. A., Palmer, M. R., Varkey, S. C., Kolodny, G. M., & Laham, R. J. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.055616 · Cited by 263 · see citing works

Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy

Davuluri, R., Jiang, W., Fang, P. Q., Xu, C., Komaki, R. R., Gomez, D. R., Welsh, J. W., Cox, J. D., Crane, C. H., Hsu, C. C.-C., et al. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.05.037 · Cited by 257 · see citing works

Evolution of acquired resistance to anti-cancer therapy

Foo, J., & Franziska Michor, A. (2014) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2014.02.025 · Cited by 252 · see citing works

A Systemic Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy

Hiniker, S. M., Chen, D. S., Reddy, S. A., Chang, D. T., Jones, J. C., Mollick, J. A., Swetter, S. M., & Knox, S. J. (2012) · Translational Oncology · doi:10.1593/tlo.12280 · Cited by 246 · see citing works

Guidelines for the labelling of leucocytes with 99mTc-HMPAO

de Vries, E. F. J., Roca, M., Jamar, F., Israel, O., & Signore, A. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1394-4 · Cited by 245 · see citing works

TGFβ1 Inhibition Increases the Radiosensitivity of Breast Cancer Cells In Vitro and Promotes Tumor Control by Radiation In Vivo

Bouquet, F., Pal, A., Pilones, K. A., Demaria, S., Hann, B. C., Akhurst, R. J., Babb, J. S., Lonning, S. M., DeWyngaert, J. K., Formenti, S. C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0544 · Cited by 240 · see citing works

Treatment-related Lymphopenia in Patients With Stage III Non-Small-Cell Lung Cancer

Campian, J. L., Ye, X., Brock, M. V., & Grossman, S. A. (2013) · Cancer Investigation · doi:10.3109/07357907.2013.767342 · Cited by 233 · see citing works

A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab

Chandra, R. A., Wilhite, T. J., Balboni, T. A., Alexander, B. M., Spektor, A., Ott, P. A., Ng, A. K., Hodi, F. S., & Schoenfeld, J. D. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1046028 · Cited by 230 · see citing works

Added Value of 99m Tc-HMPAO–Labeled Leukocyte SPECT/CT in the Characterization and Management of Patients with Infectious Endocarditis

Erba, P. A., Conti, U., Lazzeri, E., Sollini, M., Doria, R., Tommasi, S. M. D., Bandera, F., Tascini, C., Menichetti, F., Dierckx, R., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.099424 · Cited by 225 · see citing works

Correction: Corrigendum: THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors

Cayrol, F., Praditsuktavorn, P., Fernando, T. M., Kwiatkowski, N. P., Marullo, R., Calvo-Vidal, M. N., Phillip, J. M., Pera, B., Yang, S. N., Takpradit, K., et al. (2017) · Nature Communications · doi:10.1038/ncomms14747 · Cited by 220 · see citing works

Flt3-ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer.

Chakravarty, P. K., Alfieri, A. A., Thomas, E. K., Beri, V., Tanaka, K. E., Vikram, B., & Guha, C. (1999) · PubMed · Cited by 218 · see citing works

Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T Cells

Rudqvist, N.-P., Pilones, K. A., Lhuillier, C., Wennerberg, E., Sidhom, J.-W., Emerson, R., Robins, H. S., Schneck, J. P., Formenti, S. C., & Demaria, S. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0134 · Cited by 214 · see citing works

Endotoxin-induced systemic inflammation activates microglia: [11C]PBR28 positron emission tomography in nonhuman primates

Hannestad, J. O., Gallezot, J., Schafbauer, T., Lim, K., Kloczynski, T., Morris, E. D., Carson, R. E., Ding, Y., & Cosgrove, K. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.06.055 · Cited by 213 · see citing works

The Association Between Chemoradiation-related Lymphopenia and Clinical Outcomes in Patients With Locally Advanced Pancreatic Adenocarcinoma

Wild, A. T., Ye, X., Ellsworth, S. G., Smith, J. A., Narang, A. K., Garg, T., Campian, J. L., Laheru, D. A., Zheng, L., Wolfgang, C. L., et al. (2013) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3182940ff9 · Cited by 211 · see citing works

PET and SPECT in Osteomyelitis and Prosthetic Bone and Joint Infections: A Systematic Review

van der Bruggen, W., Bleeker‐Rovers, C. P., Boerman, O. C., Gotthardt, M., & Oyen, W. J. G. (2009) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2009.08.005 · Cited by 209 · see citing works

The Norton–Simon hypothesis: designing more effective and less toxic chemotherapeutic regimens

Simon, R. M., & Norton, L. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0560 · Cited by 208 · see citing works

Merkel Polyomavirus-Specific T Cells Fluctuate with Merkel Cell Carcinoma Burden and Express Therapeutically Targetable PD-1 and Tim-3 Exhaustion Markers

Afanasiev, O. K., Yelistratova, L., Miller, N. J., Nagase, K., Paulson, K. G., Iyer, J. G., Ibrani, D., Koelle, D. M., & Nghiem, P. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0035 · Cited by 205 · see citing works

Guidelines for the labelling of leucocytes with 111In-oxine

Roca, M., de Vries, E. F. J., Jamar, F., Israel, O., & Signore, A. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1393-5 · Cited by 205 · see citing works

T-cell Localization, Activation, and Clonal Expansion in Human Pancreatic Ductal Adenocarcinoma

Stromnes, I. M., Hulbert, A., Pierce, R. H., Greenberg, P. D., & Hingorani, S. R. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0322 · Cited by 201 · see citing works

CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG)

Balermpas, P., Rödel, F., Rödel, C. M., Krause, M., Linge, A., Lohaus, F., Baumann, M. A., Tinhofer, I., Budach, V., Gkika, E., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29683 · Cited by 200 · see citing works

Mathematical and computational models of immune-receptor signalling

Goldstein, B., Faeder, J. R., & Hlavacek, W. S. (2004) · Nature reviews. Immunology · doi:10.1038/nri1374 · Cited by 199 · see citing works

Abscopal, immunological effects of radiotherapy: Narrowing the gap between clinical and preclinical experiences

Brix, N., Tiefenthaller, A., Anders, H., Belka, C., & Lauber, K. (2017) · Immunological Reviews · doi:10.1111/imr.12573 · Cited by 198 · see citing works

Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging

Thu, M. S., Bryant, L. H., Coppola, T., Jordan, E. K., Budde, M. D., Lewis, B. K., Chaudhry, A., Ren, J., Varma, N. R. S., Arbab, A. S., et al. (2012) · Nature Medicine · doi:10.1038/nm.2666 · Cited by 195 · see citing works

Angiogenesis as a marker of preneoplastic lesions of the human breast

Brem, S. S., Jensen, H. M., & Gullino, P. M. (1978) · Cancer · doi:10.1002/1097-0142(197801)41:1 · Cited by 191 · see citing works

Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation

Neuwelt, A., Sidhu, N., Hu, C.-A. A., Mlady, G., Eberhardt, S. C., & Sillerud, L. O. (2015) · American Journal of Roentgenology · doi:10.2214/ajr.14.12733 · Cited by 189 · see citing works

Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors

Ellsworth, S. G. (2018) · Advances in Radiation Oncology · doi:10.1016/j.adro.2018.08.014 · Cited by 189 · see citing works

The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors

Pike, L., Bang, A., Mahal, B. A. V., Taylor, A., Krishnan, M. S., Spektor, A., Cagney, D. N., Aizer, A. A., Alexander, B. M., Rahma, O. E., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.09.010 · Cited by 185 · see citing works

What does physics have to do with cancer?

Franziska Michor, A., Liphardt, J., Mauro Ferrari, B., & Widom, J. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3092 · Cited by 177 · see citing works

In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment

Vanpouille‐Box, C., Pilones, K. A., Wennerberg, E., Formenti, S. C., & Demaria, S. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.05.105 · Cited by 176 · see citing works

Mathematical Modeling of Cancer Immunotherapy and Its Synergy with Radiotherapy

Serre, R., Benzekry, S., Padovani, L., Meille, C., André, N., Ciccolini, J., Barlési, F., Muracciole, X., & Barbolosi, D. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3567 · Cited by 174 · see citing works

Lymphocyte numbers and subsets in the human blood

Blum, K. S., & Pabst, R. (2006) · Immunology Letters · doi:10.1016/j.imlet.2006.10.009 · Cited by 171 · see citing works

Engineered antibody fragments for immuno-PET imaging of endogenous CD8 + T cells in vivo

Tavaré, R., McCracken, M. N., Zettlitz, K. A., Knowles, S. M., Salazar, F. B., Olafsen, T., Witte, O. N., & Wu, A. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316922111 · Cited by 167 · see citing works

Overexpression and gene amplification of PD-L1 in cancer cells and PD-L1+ immune cells in Epstein–Barr virus-associated gastric cancer: the prognostic implications

Saito, R., Abé, H., Kunita, A., Yamashita, H., Seto, Y., & Fukayama, M. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.202 · Cited by 158 · see citing works

The Association Between Treatment-Related Lymphopenia and Survival in Newly Diagnosed Patients with Resected Adenocarcinoma of the Pancreas

Balmanoukian, A. S., Ye, X., Herman, J. M., Laheru, D. A., & Grossman, S. A. (2012) · Cancer Investigation · doi:10.3109/07357907.2012.700987 · Cited by 154 · see citing works

Radiation-Induced Lymphocyte-Immune Deficiency

Meyer, K. K. (1970) · Archives of Surgery · doi:10.1001/archsurg.1970.01340260018003 · Cited by 146 · see citing works

Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme

Fadul, C. E., Fisher, J. L., Gui, J., Hampton, T. H., Côté, A. L., & Ernstoff, M. S. (2011) · Neuro-Oncology · doi:10.1093/neuonc/noq204 · Cited by 146 · see citing works

Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer

Lim, S. H., Hong, M. E., Ahn, S. W., Choi, Y., Kim, K.-M., Oh, D., Ahn, Y. C., Jung, S., Ahn, M., Park, K., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.09.019 · Cited by 142 · see citing works

Targeting the TGF-β1 Pathway to Prevent Normal Tissue Injury After Cancer Therapy

Anscher, M. S. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-s101 · Cited by 140 · see citing works

Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer

Guthrie, G. J. K., Roxburgh, C. S. D., Farhan‐Alanie, O. M., Horgan, P. G., & McMillan, D. C. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.330 · Cited by 136 · see citing works

Molecular Imaging of CXCR4 Receptor Expression in Human Cancer Xenografts with [64Cu]AMD3100 Positron Emission Tomography

Nimmagadda, S., Pullambhatla, M., Stone, K. L., Green, G. M., Bhujwalla, Z. M., & Pomper, M. G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4396 · Cited by 135 · see citing works

68Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with18F-FDG, calcium burden and risk factors

Li, X., Samnick, S., Lapa, C., Israel, I., Buck, A. K., Kreissl, M. C., & Bauer, W. R. (2012) · EJNMMI Research · doi:10.1186/2191-219x-2-52 · Cited by 125 · see citing works

Mature B cells accelerate wound healing after acute and chronic diabetic skin lesions

Sîrbulescu, R. F., Boehm, C. K., Soon, E., Wilks, M. Q., Ilieş, I., Yuan, H., Maxner, B., Chronos, N. A. F., Kaittanis, C., Normandin, M. D., et al. (2017) · Wound Repair and Regeneration · doi:10.1111/wrr.12584 · Cited by 123 · see citing works

Abscopal Benefits of Localized Radiotherapy Depend on Activated T-cell Trafficking and Distribution between Metastatic Lesions

Poleszczuk, J., Luddy, K. A., Prokopiou, S., Robertson‐Tessi, M., Moros, E. G., Fishman, M., Djeu, J. Y., Finkelstein, S. E., & Enderling, H. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1423 · Cited by 119 · see citing works

Noninvasive PET Imaging of T cells

Wei, W., Jiang, D., Ehlerding, E. B., Luo, Q., & Cai, W. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.03.009 · Cited by 119 · see citing works

Association between treatment-related lymphopenia and overall survival in elderly patients with newly diagnosed glioblastoma

Mendez, J. S., Govindan, A., Leong, J., Gao, F., Huang, J., & Campian, J. L. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-2037-1 · Cited by 117 · see citing works

Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy?

Chadha, A. S., Liu, G., Chen, H.-C., Das, P., Minsky, B. D., Mahmood, U. X., Delclos, M. E., Suh, Y., Sawakuchi, G. O., Beddar, S. A., et al. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.10.046 · Cited by 111 · see citing works

A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma

Crocenzi, T. S., Cottam, B., Newell, P., Wolf, R., Hansen, P., Hammill, C. W., Solhjem, M. C., To, Y.-Y., Greathouse, A., Tormoen, G. W., et al. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0149-6 · Cited by 109 · see citing works

Predator-prey equations simulating an immune response

Bell, G. I. (1973) · Mathematical Biosciences · doi:10.1016/0025-5564(73)90036-9 · Cited by 106 · see citing works

Human papilloma virus load and PD-1/PD-L1, CD8 + and FOXP3 in anal cancer patients treated with chemoradiotherapy: Rationale for immunotherapy

Balermpas, P., Martin, D., Wieland, U., Rave‐Fränk, M., Strebhardt, K., Rödel, C. M., Fokas, E., & Rödel, F. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1288331 · Cited by 106 · see citing works

Radiation and PD-(L)1 treatment combinations: immune response and dose optimization via a predictive systems model

Kosinsky, Y., Dovedi, S. J., Peskov, K. V., Voronova, V., Chu, L., Tomkinson, H. K., Al-Huniti, N. H., Stanski, D. R., & Helmlinger, G. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0327-9 · Cited by 105 · see citing works

Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaque

Camici, P. G., Rimoldi, O. E., Gaemperli, O., & Libby, P. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs067 · Cited by 104 · see citing works

Effect of Radiation Treatment Volume Reduction on Lymphopenia in Patients Receiving Chemoradiotherapy for Glioblastoma

Rudra, S. F., Hui, C., Rao, Y. J., Samson, P. P., Lin, A. J., Chang, X., Tsien, C. I., Fergus, S., Mullen, D. F., Yang, D., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.01.069 · Cited by 104 · see citing works

In vivo nanoparticle imaging of innate immune cells can serve as a marker of disease severity in a model of multiple sclerosis

Kirschbaum, K., Sonner, J. K., Zeller, M. W. G., Deumelandt, K., Bode, J., Sharma, R. K., Krüwel, T., Fischer, M. D., Hoffmann, A., da Silva, M. C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609397113 · Cited by 103 · see citing works

Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy

Chen, H.-M., Ma, G., Gildener‐Leapman, N., Eisenstein, S. G., Coakley, B. A., Ozao, J. J., Mandeli, J., Divino, C. M., Schwartz, M., Sung, M. W., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2742 · Cited by 102 · see citing works

Chemoradiotherapy-Induced Upregulation of PD-1 Antagonizes Immunity to HPV-Related Oropharyngeal Cancer

Parikh, F. S., Duluc, D., Imai, N., Clark, A., Misiukiewicz, K., Bonomi, M., Gupta, V., Patsias, A., Parides, M. K., Demicco, E. G., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1913 · Cited by 102 · see citing works

Radiation-related lymphopenia as a new prognostic factor in limited-stage small cell lung cancer

Cho, O., Oh, Y., Chun, M., Noh, O. K., & Lee, H. W. (2015) · Tumor Biology · doi:10.1007/s13277-015-3888-y · Cited by 90 · see citing works

Advances in SPECT and PET Hardware

Slomka, P. J., Pan, T., Berman, D. S., & Germano, G. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.02.002 · Cited by 88 · see citing works

Behavior of tumors under nonstationary therapy

Sotolongo-Costa, O., Molina, L. M., Pérez, D. R., Antoranz, J. C., & Reyes, M. C. (2003) · Physica D Nonlinear Phenomena · doi:10.1016/s0167-2789(03)00005-8 · Cited by 88 · see citing works

Chemoradiation-Induced Alteration of Programmed Death-Ligand 1 and CD8+ Tumor-Infiltrating Lymphocytes Identified Patients With Poor Prognosis in Rectal Cancer: A Matched Comparison Analysis

Lim, Y. J., Koh, J., Kim, S., Jeon, S. R., Chie, E. K., Kim, K., Kang, G. H., Han, S., Kim, T., Jeong, S., et al. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.07.004 · Cited by 87 · see citing works

Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes

Fernandes, A., Shen, J., Finlay, J. C., Mitra, N., Evans, T. L., Stevenson, J. P., Langer, C. J., Lin, L. L., Hahn, S. M., GLATSTEIN, E. J., et al. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.02.007 · Cited by 86 · see citing works

Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients

Fujimoto, D., Uehara, K., Sato, Y., Sakanoue, I., Ito, M., Teraoka, S., Nagata, K., Nakagawa, A., Kosaka, Y., Otsuka, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11949-9 · Cited by 86 · see citing works

The Immunoimaging Toolbox

Mayer, A. T., & Gambhir, S. S. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.185967 · Cited by 85 · see citing works

The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients

Liu, L., Chen, Q.-Y., Tang, L., Guo, S.-S., Guo, L., Mo, H., Chen, M., Zhao, C., Guo, X., Qian, C.-N., et al. (2017) · Cancer Research and Treatment · doi:10.4143/crt.2016.595 · Cited by 80 · see citing works

Sustained CD4+T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomide

Ellsworth, S. G., Balmanoukian, A. S., Kos, F. J., Nirschl, C. J., Nirschl, T. R., Grossman, S. A., Luznik, L., & Drake, C. G. (2014) · OncoImmunology · doi:10.4161/onci.27357 · Cited by 78 · see citing works

11C-PBR28 and 18F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple Sclerosis

Datta, G., Colasanti, A., Kalk, N., Owen, D. R., Scott, G. P. T., Rabiner, E., Gunn, R., Lingford-Hughes, A., Malik, O., Ciccarelli, O., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.187161 · Cited by 78 · see citing works

Kill and Spread the Word: Stimulation of Antitumor Immune Responses in the Context of Radiotherapy

Gaipl, U. S., Multhoff, G., Scheithauer, H., Lauber, K., Hehlgans, S., Frey, B., & Rödel, F. (2014) · Immunotherapy · doi:10.2217/imt.14.38 · Cited by 74 · see citing works

Recombinant Anti-CD20 Antibody Fragments for Small-Animal PET Imaging of B-Cell Lymphomas

Olafsen, T., Betting, D. J., Kenanova, V. E., Salazar, F. B., Clarke, P. J., SAID, J. W., Raubitschek, A. A., Timmerman, J. M., & Wu, A. M. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.060426 · Cited by 74 · see citing works

Prognostic Value of Severe Lymphopenia During Pelvic Concurrent Chemoradiotherapy in Cervical Cancer.

Cho, O., Chun, M., Chang, S., Yt, O., & Ok, N. (2016) · PubMed · Cited by 74 · see citing works

The clinical and prognostic significance of CD14+HLA-DR−/low myeloid-derived suppressor cells in hepatocellular carcinoma patients receiving radiotherapy

Wang, D., An, G., Xie, S., Yao, Y., & Feng, G. (2016) · Tumor Biology · doi:10.1007/s13277-016-4916-2 · Cited by 73 · see citing works

Gadolinium(III)-Gold Nanorods for MRI and Photoacoustic Imaging Dual-Modality Detection of Macrophages in Atherosclerotic Inflammation

Qin, H., Zhou, T., Yang, S., Chen, Q., & Xing, D. (2013) · Nanomedicine · doi:10.2217/nnm.12.168 · Cited by 72 · see citing works

Magnetoelectroporation: improved labeling of neural stem cells and leukocytes for cellular magnetic resonance imaging using a single FDA-approved agent

Walczak, P., Ruı́z-Cabello, J., Kedziorek, D., Gilad, A. A., Lin, S., Barnett, B. P., Lu, Q., Levitsky, H. I., & Bulte, J. W. M. (2006) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2006.01.003 · Cited by 71 · see citing works

T cell receptor sequencing of early-stage breast cancer tumors identifies altered clonal structure of the T cell repertoire

Beausang, J. F., Wheeler, A. J., Chan, N. H., Hanft, V. R., Dirbas, F. M., Jeffrey, S. S., & Quake, S. R. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1713863114 · Cited by 70 · see citing works

Modeling Spontaneous Metastasis following Surgery: An In Vivo-In Silico Approach

Benzekry, S., Tracz, A., Mastri, M., Corbelli, R., Barbolosi, D., & Ebos, J. M. L. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1389 · Cited by 69 · see citing works

Nuclear medicine and infection detection: the relative effectiveness of imaging with 111In-oxine-, 99mTc-HMPAO-, and 99mTc-stannous fluoride colloid-labeled leukocytes and with 67Ga-citrate.

Hughes, D. K. (2003) · PubMed · Cited by 69 · see citing works

Increased diversity with reduced “diversity evenness” of tumor infiltrating T-cells for the successful cancer immunotherapy

Hosoi, A., Takeda, K., Nagaoka, K., Iino, T., Matsushita, H., Ueha, S., Aoki, S., Matsushima, K., Kubo, M., Morikawa, T., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19548-y · Cited by 69 · see citing works

Prognostic and Predictive Significance of Plasma HGF and IL-8 in a Phase III Trial of Chemoradiation with or without Tirapazamine in Locoregionally Advanced Head and Neck Cancer

Le, Q., Fisher, R., Oliner, K. S., Young, R. J., Cao, H., Kong, C. S., Graves, E. E., Hicks, R. J., McArthur, G. A., Peters, L., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2094 · Cited by 66 · see citing works

Iron overload by Superparamagnetic Iron Oxide Nanoparticles is a High Risk Factor in Cirrhosis by a Systems Toxicology Assessment

Wei, Y., Zhao, M., Yang, F., Mao, Y., Xie, H., & Zhou, Q. (2016) · Scientific Reports · doi:10.1038/srep29110 · Cited by 65 · see citing works

Serial changes in lymphocyte subsets in patients with newly diagnosed high grade astrocytomas treated with standard radiation and temozolomide

Campian, J. L., Piotrowski, A., Ye, X., Hakim, F. T., Rose, J. J., Yan, X.-Y., Lu, Y., Gress, R. E., & Grossman, S. A. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2580-z · Cited by 62 · see citing works

The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor Immunity

Poleszczuk, J., & Enderling, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113377 · Cited by 62 · see citing works

High ratio of programmed cell death protein 1 (PD-1)+/CD8+ tumor-infiltrating lymphocytes identifies a poor prognostic subset of extrahepatic bile duct cancer undergoing surgery plus adjuvant chemoradiotherapy

Lim, Y. J., Koh, J., Kim, K., Chie, E. K., Kim, B., Lee, K. B., Jang, J., Kim, S., Oh, D., Bang, Y., et al. (2015) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2015.07.003 · Cited by 61 · see citing works

PET/CT Imaging of Inflammatory Bowel Disease

Perlman, S. B., Hall, B. S., & Reichelderfer, M. (2013) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2013.06.006 · Cited by 60 · see citing works

Combination of direct intratumoral administration of dendritic cells and irradiation induces strong systemic antitumor effect mediated by GRP94/gp96 against squamous cell carcinoma in mice

Akutsu, Y., Matsubara, H., Urashima, T., Komatsu, A., Sakata, H., Nishimori, T., Yoneyama, Y., Hoshino, I., Murakami, K., Usui, A., et al. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.3.509 · Cited by 56 · see citing works

FDG–PET can distinguish inflamed from non-inflamed plaque in an animal model of atherosclerosis

Davies, J. R., Izquierdo‐Garcia, D., Rudd, J. H. F., Figg, N. L., Richards, H. K., Bird, J., Aigbirhio, F. I., Davenport, A. P., Weissberg, P. L., Fryer, T. D., et al. (2009) · International journal of cardiac imaging · doi:10.1007/s10554-009-9506-6 · Cited by 53 · see citing works

Combined immunotherapy and radiation for treatment of mucosal melanomas of the lower genital tract

Schiavone, M. B., Broach, V. A., Shoushtari, A. N., Carvajal, R. D., Alektiar, K. M., Kollmeier, M. A., Abu‐Rustum, N. R., & Leitão, M. M. (2016) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2016.04.001 · Cited by 53 · see citing works

Involved field radiotherapy (IFRT) versus elective nodal irradiation (ENI) for locally advanced non-small cell lung cancer: a meta-analysis of incidence of elective nodal failure (ENF)

Li, R., Yu, L., Lin, S., Wang, L., Dong, X., Yu, L., Li, W., & Li, B. (2016) · Radiation Oncology · doi:10.1186/s13014-016-0698-3 · Cited by 52 · see citing works

Heat-induced radiolabeling and fluorescence labeling of Feraheme nanoparticles for PET/SPECT imaging and flow cytometry

Yuan, H., Wilks, M. Q., Normandin, M. D., Fakhri, G. E., Kaittanis, C., & Josephson, L. (2018) · Nature Protocols · doi:10.1038/nprot.2017.133 · Cited by 52 · see citing works

ImmunoPET of Malignant and Normal B Cells with 89Zr- and 124I-Labeled Obinutuzumab Antibody Fragments Reveals Differential CD20 Internalization In Vivo

Zettlitz, K. A., Tavaré, R., Knowles, S. M., Steward, K. K., Timmerman, J. M., & Wu, A. M. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0855 · Cited by 51 · see citing works

Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion

Saby, L., Habib, G., Laas, O., Cammilleri, S., Casalta, J., Gouriet, F., Ribéri, A., Aviérinos, J.-F., Raoult, D., & Thuny, F. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht311.5950 · Cited by 50 · see citing works

Mathematical Modeling in Immunotherapy of Cancer: Personalizing Clinical Trials

Agur, Z., & Vuk‐Pavlović, S. (2012) · Molecular Therapy · doi:10.1038/mt.2011.272 · Cited by 48 · see citing works

From concept to clinic: Mathematically informed immunotherapy

Walker, R., & Enderling, H. (2015) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2015.10.004 · Cited by 46 · see citing works

Immune interconnectivity of anatomically distant tumors as a potential mediator of systemic responses to local therapy

Walker, R., Poleszczuk, J., Pilon‐Thomas, S., Kim, S., Anderson, A. R. A., Czerniecki, B. J., Harrison, L. B., Moros, E. G., & Enderling, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-27718-1 · Cited by 45 · see citing works

Assessment of vulnerable atherosclerotic and fibrotic plaques in coronary arteries using (68)Ga-DOTATATE PET/CT.

Mojtahedi, A., Alavi, A. A., Thamake, S. I., Amerinia, R., Ranganathan, D., Tworowska, I., & Delpassand, E. S. (2015) · Europe PMC (PubMed Central) · Cited by 43 · see citing works

Imaging of the Vulnerable Carotid Plaque: Biological Targeting of Inflammation in Atherosclerosis using Iron Oxide Particles and MRI

Chan, J. M. S., Monaco, C. G., Wylezinska, M., Tremoleda, J. L., & Gibbs, R. G. J. (2014) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2014.01.017 · Cited by 43 · see citing works

Resisting Resistance

Božić, I., & Nowak, M. A. (2016) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-042716-094839 · Cited by 42 · see citing works

Implementation of 89Zr production and in vivo imaging of B-cells in mice with 89Zr-labeled anti-B-cell antibodies by small animal PET/CT

Walther, M., Gebhardt, P., Grosse‐Gehling, P., Würbach, L., Irmler, I. M., Preusche, S., Khalid, M., Opfermann, T., Kamradt, T., Steinbach, J., et al. (2011) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2011.02.040 · Cited by 39 · see citing works

Programmed Death Ligand 1 Expression in Paired Non–Small Cell Lung Cancer Tumor Samples

Cho, J. H., Sorensen, S. F., Choi, Y., Feng, Y., Kim, T., Choi, H., Georgsen, J. B., Dolled-Filhart, M. P., Emancipator, K., Meldgaard, P., et al. (2017) · Clinical Lung Cancer · doi:10.1016/j.cllc.2017.04.008 · Cited by 39 · see citing works

Application of a Novel CD206+ Macrophage-Specific Arterial Imaging Strategy in HIV-Infected Individuals

Zanni, M. V., Toribio, M. P., Wilks, M. Q., Lu, M. T., Burdo, T. H., Walker, J., Autissier, P., Foldyna, B., Stone, L. A., Martin, A., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix095 · Cited by 39 · see citing works

MPI cell tracking: what can we learn from MRI?

Bulte, J. W. M., Walczak, P., Gleich, B., Weizenecker, J., Markov, D. E., Aerts, H. C. J., Boeve, H., Borgert, J., & Kuhn, M. H. (2011) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.879844 · Cited by 37 · see citing works

Inflammatory Bowel Disease: MR- and SPECT/CT-based Macrophage Imaging for Monitoring and Evaluating Disease Activity in Experimental Mouse Model—Pilot Study

Wu, Y., Briley-Saebo, K. C., Xie, J., Ruihua, Z., Wang, Z., He, C., Tang, C. Y., & Tao, X. (2014) · Radiology · doi:10.1148/radiol.13122254 · Cited by 37 · see citing works

Peripheral lymphocyte subset variation predicts prostate cancer carbon ion radiotherapy outcomes

Yang, Z., Zhao, N., Meng, J., Shi, Z., Li, B.-X., Wu, X., Li, P., Zhang, Q., Wei, X., & Fu, S. (2016) · Oncotarget · doi:10.18632/oncotarget.8389 · Cited by 36 · see citing works

Influence of PD-L1 expression in immune cells on the response to radiation therapy in patients with oropharyngeal squamous cell carcinoma

Fukushima, Y., Someya, M., Nakata, K., Hori, M., Kitagawa, M., Hasegawa, T., Tsuchiya, T., Gocho, T., Ikeda, H., Hirohashi, Y., et al. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.08.023 · Cited by 36 · see citing works

General Aspects of Modeling Tumor Growth and Immune Response

Adam, J. (1997) · Birkhäuser Boston eBooks · doi:10.1007/978-0-8176-8119-7_2 · Cited by 35 · see citing works

Differential Association Between Circulating Lymphocyte Populations With Outcome After Radiation Therapy in Subtypes of Liver Cancer

Grassberger, C., Hong, T. S., Hato, T., Yeap, B. Y., Wo, J. Y.-L., Tracy, M., Bortfeld, T. R., Wolfgang, J. A., Eyler, C. E., Goyal, L., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.04.026 · Cited by 35 · see citing works

Omitting elective nodal irradiation during thoracic irradiation in limited-stage small cell lung cancer – Evidence from a phase II trial

Colaco, R. J., Sheikh, H. Y., Lorigan, P. C., Blackhall, F. H., Hulse, P. A., Califano, R., Ashcroft, L., Taylor, P., Thatcher, N. J., & Finn, C. F. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.09.015 · Cited by 32 · see citing works

Heat‐Induced Radiolabeling of Nanoparticles for Monocyte Tracking by PET

Normandin, M. D., Yuan, H., Wilks, M. Q., Chen, H. H., Kinsella, J. M., Cho, H., Guehl, N. J., Absi‐Halabi, N., Hosseini, S. M., Fakhri, G. E., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201505525 · Cited by 31 · see citing works

Involved field irradiation for the treatment of esophageal cancer: Is it better than elective nodal irradiation?

Jiang, L., Zhao, X., Meng, X., & Yu, J. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.11.045 · Cited by 27 · see citing works

Bone Marrow Transplantation Alters the Tremor Phenotype in the Murine Model of Globoid-Cell Leukodystrophy

Reddy, A. S., Wozniak, D. F., Farber, N. B., Dearborn, J. T., Fowler, S. C., & Sands, M. S. (2012) · Journal of Clinical Medicine · doi:10.3390/jcm1010001 · Cited by 26 · see citing works

Models of Models: A Translational Route for Cancer Treatment and Drug Development

Ogilvie, L. A., Kovachev, A., Wierling, C., Lange, B. M. H., & Lehrach, H. R. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00219 · Cited by 26 · see citing works

Comparison between Tc-HMPAO labelled white cells and Tc LeukoScan in the investigation of inflammatory bowel disease

Kerry, J., Marshall, C., Griffiths, P. A., James, M. W., & SCOTT, B. B. (2005) · Nuclear Medicine Communications · doi:10.1097/00006231-200503000-00009 · Cited by 25 · see citing works

Immunologically effective dose: a practical model for immuno-radiotherapy

Serre, R., Barlési, F., Muracciole, X., & Barbolosi, D. (2018) · Oncotarget · doi:10.18632/oncotarget.25746 · Cited by 25 · see citing works

Imaging of carrageenan-induced local inflammation and adjuvant-induced systemic arthritis with [11C]PBR28 PET

Shao, X., Wang, X., English, S. J., Desmond, T. J., Sherman, P. S., Quesada, C., & Piert, M. (2013) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2013.06.008 · Cited by 24 · see citing works

Immunotherapy in Non-Small-Cell Lung Cancer: Potential Predictors of Response and New Strategies to Assess Activity

Rossi, S., Castello, A., Toschi, L., & Lopci, E. (2018) · Immunotherapy · doi:10.2217/imt-2017-0187 · Cited by 23 · see citing works

New SPECT and PET Radiopharmaceuticals for Imaging Inflammatory Diseases: A Meta-analysis of the Last 10 Years.

Pacilio, M., Lauri, C., Prosperi, D., Petitti, A., & Signore, A. (2018) · Seminars in nuclear medicine · doi:10.1053/j.semnuclmed.2017.12.004 · Cited by 22 · see citing works

Methodologies in the modeling of combined chemo-radiation treatments

Grassberger, C., & Paganetti, H. (2016) · Physics in Medicine and Biology · doi:10.1088/0031-9155/61/21/r344 · Cited by 22 · see citing works

Mathematical modelling of the synergistic combination of radiotherapy and indoleamine-2,3-dioxygenase (IDO) inhibitory immunotherapy against glioblastoma

Chakwizira, A., Ahlstedt, J., Redebrandt, H. N., & Ceberg, C. P. (2018) · British Journal of Radiology · doi:10.1259/bjr.20170857 · Cited by 22 · see citing works

The Utility of Pretreatment and Posttreatment Lymphopenia in Cervical Squamous Cell Carcinoma Patients Treated With Definitive Chemoradiotherapy

Önal, C., Yıldırım, B. A., Güler, O. C., & Mertsoylu, H. (2018) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000001345 · Cited by 22 · see citing works

Effect of CD4 Count on Treatment Toxicity and Tumor Recurrence in Human Immunodeficiency Virus–Positive Patients With Anal Cancer

Bryant, A. K., Mudgway, R., Huynh‐Le, M., Simpson, D. R., Mell, L. K., Gupta, S. N., Sharabi, A. B., & Murphy, J. D. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.09.034 · Cited by 21 · see citing works

Radiation-induced melanoma-associated leucoderma, systemic antimelanoma immunity and disease-free survival in a patient with advanced-stage melanoma: a case report and immunological analysis

Teulings, H. E., Tjin, E. P. M., Willemsen, K. J., Krebbers, G., van Noesel, C. J. M., Kemp, E. H., Nieuweboer‐Krobotová, L., van der Veen, J. P. W., & Luiten, R. M. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12136 · Cited by 20 · see citing works

Varied Effects of Thoracic Irradiation on Peripheral Lymphocyte Subsets in Lung Cancer Patients.

NAKAYAMA, Y., Makino, S., Fukuda, Y., Min, K., Ikemoto, T., Shimizu, A., & Ohsawa, N. (1995) · Internal Medicine · doi:10.2169/internalmedicine.34.959 · Cited by 20 · see citing works

Heat-induced-radiolabeling and click chemistry: A powerful combination for generating multifunctional nanomaterials

Yuan, H., Wilks, M. Q., Fakhri, G. E., Normandin, M. D., Kaittanis, C., & Josephson, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172722 · Cited by 19 · see citing works

TGF-β inhibits IL-7-induced proliferation in memory but not naive human CD4+ T cells

Nguyen, T. P., & Sieg, S. F. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a1216-520rr · Cited by 19 · see citing works

Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality

Evans, R. L., Pottala, J. V., Nagata, S., & Egland, K. A. (2018) · BMC Cancer · doi:10.1186/s12885-018-4022-5 · Cited by 19 · see citing works

Transcriptome analysis of low-dose ionizing radiation-impacted genes in CD4 + T-cells undergoing activation and regulation of their expression of select cytokines

Cho, S.-J., Kang, H., Hong, E., Kim, J.-Y., & Nam, S. Y. (2018) · Journal of Immunotoxicology · doi:10.1080/1547691x.2018.1521484 · Cited by 19 · see citing works

The inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approach

Cope, F. O., Abbruzzese, B. C., Sanders, J., Metz, W., Sturms, K., Ralph, D. A., Blue, M., Zhang, J., Bracci, P. M., Bshara, W., et al. (2015) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2015.11.007 · Cited by 17 · see citing works

Pitfalls and Limitations of SPECT, PET, and Therapeutic Radiopharmaceuticals

Ballinger, J. R. (2015) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2015.02.007 · Cited by 16 · see citing works

Essential Elements to Consider for MRI Cell Tracking Studies with Iron Oxide-based Labeling Agents.

Wang, P. C., & Shan, L. (2012) · PubMed · Cited by 15 · see citing works

Diagnose septischer Hüftprothesenlockerung via LeukoScan

Kaisidis, A., Megas, P., Apostolopoulos, D., Spiridonidis, T., Koumoundourou, D., Zouboulis, P., Lambiris, E., & Vassilakos, P. (2005) · Der Orthopäde · doi:10.1007/s00132-005-0777-x · Cited by 14 · see citing works

Cold and hot tumors: from molecular mechanisms to targeted therapy

Wu, B., Zhang, B., Li, B., Wu, H., & Jiang, M. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01979-x · Cited by 751 · see citing works

Molecular Mechanisms of Radiation-Induced Cancer Cell Death: A Primer

Sia, J., Szmyd, R., Hau, E., & Gee, H. E. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00041 · Cited by 378 · see citing works

Towards clinical translation of FLASH radiotherapy

Vozenin, M., Bourhis, J., & Durante, M. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00697-z · Cited by 370 · see citing works

Electromagnetic Nanomedicines for Combinational Cancer Immunotherapy

Li, J., Luo, Y., & Pu, K. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202008386 · Cited by 222 · see citing works

Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer

Mirzaei, S., Gholami, M. H., Zabolian, A., Saleki, H., Farahani, M. V., Hamzehlou, S., Far, F. B., Sharifzadeh, S. O., Samarghandian, S., Khan, H. Z., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105759 · Cited by 189 · see citing works

Interfering with Tumor Hypoxia for Radiotherapy Optimization

Telarović, I., Wenger, R. H., & Pruschy, M. N. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02000-x · Cited by 196 · see citing works

Physics and biomedical challenges of cancer therapy with accelerated heavy ions

Durante, M., Debus, J., & Loeffler, J. S. (2021) · Nature Reviews Physics · doi:10.1038/s42254-021-00368-5 · Cited by 171 · see citing works

Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation

Sims, T. T., El Alam, M. B., Karpinets, T. V., Dorta-Estremera, S., Hegde, V. L., Nookala, S., Yoshida-Court, K., Wu, X., Biegert, G. W. G., Delgado Medrano, A. Y., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01741-x · Cited by 135 · see citing works

Toll-like receptor 9 agonists and combination therapies: strategies to modulate the tumour immune microenvironment for systemic anti-tumour immunity

Dongye, Z., Li, J., & Wu, Y. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01876-6 · Cited by 135 · see citing works

Analyzing the mechanisms of iron oxide nanoparticles interactions with cells: A road from failure to success in clinical applications

Frtús, A., Smolková, B., Uzhytchak, M., Lunová, M., Jirsa, M., Kubinová, Š., Dejneka, A., & Lunov, O. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.036 · Cited by 118 · see citing works

Tumor Microenvironment as a Regulator of Radiation Therapy: New Insights into Stromal-Mediated Radioresistance

Krisnawan, V. E., Stanley, J. A., Schwarz, J. K., & DeNardo, D. G. (2020) · Cancers · doi:10.3390/cancers12102916 · Cited by 114 · see citing works

Checkpoint Inhibitors in Combination With Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors

Spaas, M., Sundahl, N., Krüse, V., Rottey, S., Maeseneer, D. J. D., Duprez, F., Lievens, Y. N., Surmont, V. F. M., Brochez, L., Reynders, D., et al. (2023) · JAMA Oncology · doi:10.1001/jamaoncol.2023.2132 · Cited by 104 · see citing works

X‐ray‐Induced Release of Nitric Oxide from Hafnium‐Based Nanoradiosensitizers for Enhanced Radio‐Immunotherapy

Liu, N., Zhu, J., Zhu, W., Chen, L., Li, M., Shen, J., Chen, M., Wu, Y., Pan, F., Deng, Z., et al. (2023) · Advanced Materials · doi:10.1002/adma.202302220 · Cited by 103 · see citing works

Effect of neoadjuvant chemoradiotherapy with or without PD-1 antibody sintilimab in pMMR locally advanced rectal cancer: A randomized clinical trial

Xiao, W., Chen, G., Gao, Y., Lin, J., Wu, X., Luo, H.-L., Lu, Z., Wang, Q., Sun, R., Cai, P., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.07.004 · Cited by 104 · see citing works

Harnessing progress in radiotherapy for global cancer control

Jaffray, D. A., Knaul, F. M., Baumann, M. A., & Gospodarowicz, M. K. (2023) · Nature Cancer · doi:10.1038/s43018-023-00619-7 · Cited by 95 · see citing works

Oxygen-Independent Radiodynamic Therapy: Radiation-Boosted Chemodynamics for Reprogramming the Tumor Immune Environment and Enhancing Antitumor Immune Response

Chen, Y., Deng, Y., Li, Y., Qin, Y., Zhou, Z., Yang, H., & Sun, Y. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c00793 · Cited by 93 · see citing works

Myeloid-Derived Suppressor Cells and Radiotherapy

Jiménez‐Cortegana, C., Galassi, C., Klapp, V., Gabrilovich, D. I., & Galluzzi, L. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-1105 · Cited by 88 · see citing works

Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation.

Li, H.-N., Luo, Q., Zhang, H., Ma, X.-L., Gu, Z., Gong, Q.-Y., & Luo, K. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00437b · Cited by 52 · see citing works

Emerging Technologies for Local Cancer Treatment

Chua, C. Y. X., Ho, J., Demaria, S., Mauro Ferrari, B., & Grattoni, A. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000027 · Cited by 85 · see citing works

Immune-based combination therapy to convert immunologically cold tumors into hot tumors: an update and new insights

Ni, J., Zhang, Z., Ge, M.-J., Chen, J., & Zhuo, W. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00953-z · Cited by 84 · see citing works

News on immune checkpoint inhibitors as immunotherapy strategies in adult and pediatric solid tumors

Melaiu, O., Lucarini, V., Giovannoni, R., Fruci, D., & Gemignani, F. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.07.001 · Cited by 75 · see citing works

Meningeal lymphatics regulate radiotherapy efficacy through modulating anti-tumor immunity

Zhou, C., Ma, L., Xu, H., Huo, Y., & Luo, J. (2022) · Cell Research · doi:10.1038/s41422-022-00639-5 · Cited by 75 · see citing works

Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model

Philippou, Y., Sjoberg, H. T., Murphy, E. A., Alyacoubi, S., Jones, K. I., Gordon-Weeks, A. N., Phyu, S. M., Parkes, E. E., McKenna, W. G., Lamb, A. D. G., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0956-x · Cited by 72 · see citing works

Changes in T Lymphocyte Subsets in Different Tumors Before and After Radiotherapy: A Meta-analysis

Wang, Q. L., Li, S., Qiao, S., Zheng, Z., Duan, X., & Zhu, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.648652 · Cited by 72 · see citing works

Ionizing Radiation Triggers the Antitumor Immunity by Inducing Gasdermin E-Mediated Pyroptosis in Tumor Cells

Cao, W., Chen, G., Wu, L., Yu, K. N., Sun, M., Yang, M., Jiang, Y., Jiang, Y., Yuan, X., Peng, S., et al. (2022) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2022.07.1841 · Cited by 72 · see citing works

Harnessing immune response using reactive oxygen Species-Generating/Eliminating inorganic biomaterials for disease treatment

Zhao, C., Deng, H., & Chen, X. S. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114456 · Cited by 69 · see citing works

Monocyte programming by cancer therapy

Patysheva, M. R., Frolova, A. A., Larionova, I., Afanas’ev, S. G., Тарасова, А. С., Чердынцева, Н. В., & Kzhyshkowska, J. G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.994319 · Cited by 64 · see citing works

Advances in radiotherapy and immunity in hepatocellular carcinoma

Yang, Y., Xiong, L., Li, M., Jiang, P., Wang, J., & Li, C. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04386-y · Cited by 65 · see citing works

Shielding Ferritin with a Biomineralized Shell Enables Efficient Modulation of Tumor Microenvironment and Targeted Delivery of Diverse Therapeutic Agents

Wang, C., Wang, X., Zhang, W., Ma, D., Li, F., Jia, R., Shi, M., Wang, Y., Ma, G., & Wei, W. (2021) · Advanced Materials · doi:10.1002/adma.202107150 · Cited by 62 · see citing works

An Immunocompetent Hafnium Oxide-Based STING Nanoagonist for Cancer Radio-immunotherapy

Cao, Y., Ding, S., Hu, Y., Zeng, L., Zhou, J., Lin, L., Zhang, X., Ma, Q., Cai, R., Zhang, Y., et al. (2024) · ACS Nano · doi:10.1021/acsnano.3c09293 · Cited by 62 · see citing works

Opportunities and challenges of targeting cGAS–STING in cancer

Lu, C., Wang, W., & Fu, Y. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-025-00894-9 · Cited by 70 · see citing works

4D blood flow model for dose calculation to circulating blood and lymphocytes

Hammi, A., Paganetti, H., & Grassberger, C. (2020) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ab6c41 · Cited by 60 · see citing works

Combined radiotherapy and immunotherapy in urothelial bladder cancer: harnessing the full potential of the anti-tumor immune response

Faye, M. D., Kassouf, W., Souhami, L., Marcq, G., Cury, F., Niazi, T. M., & Sargos, P. (2020) · World Journal of Urology · doi:10.1007/s00345-020-03440-4 · Cited by 60 · see citing works

Photothermal‐Triggered Sulfur Oxide Gas Therapy Augments Type I Photodynamic Therapy for Potentiating Cancer Stem Cell Ablation and Inhibiting Radioresistant Tumor Recurrence

Zhang, T., You, P., Suo, M., Lyu, M., Lam, J. W. Y., Jin, Z., Ning, S., & Tang, B. Z. (2023) · Advanced Science · doi:10.1002/advs.202304042 · Cited by 59 · see citing works

Molecular determinants of immunogenic cell death elicited by radiation therapy

Galassi, C., Klapp, V., Yamazaki, T., & Galluzzi, L. (2023) · Immunological Reviews · doi:10.1111/imr.13271 · Cited by 63 · see citing works

Advanced strategies for combinational immunotherapy of cancer based on polymeric nanomedicines

You, K., Wang, Q., Osman, M. S., Kim, D., Li, Q., Feng, C., Wang, L., & Yang, K. (2024) · BMEMat · doi:10.1002/bmm2.12067 · Cited by 58 · see citing works

HEDOS—a computational tool to assess radiation dose to circulating blood cells during external beam radiotherapy based on whole-body blood flow simulations

Shin, J., Xing, S., McCullum, L. B., Hammi, A., Pursley, J., Correa-Alfonso, C. M., Withrow, J. D., Domal, S. J., Bolch, W. E., Paganetti, H., et al. (2021) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ac16ea · Cited by 61 · see citing works

A PD‐L1 siRNA‐Loaded Boron Nanoparticle for Targeted Cancer Radiotherapy and Immunotherapy

Deng, S., Hu, L., Chen, G., Ye, J., Xiao, Z., Guan, T., Guo, S., Xia, W., Cheng, D., Wan, X., et al. (2025) · Advanced Materials · doi:10.1002/adma.202419418 · Cited by 57 · see citing works

DNA Damage Baseline Predicts Resilience to Space Radiation and Radiotherapy

Pariset, E., Bertucci, A., Petay, M., Malkani, S., Lopez Macha, A., Paulino Lima, I. G., Gomez Gonzalez, V., Tin, A. S., Tang, J., Plante, I., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108434 · Cited by 56 · see citing works

Nanozyme‐Coated Bacteria Hitchhike on CD11b + Immune Cells to Boost Tumor Radioimmunotherapy

Li, H., Pei, P., He, Q., Dong, X., Zhang, C., Shen, W., Chen, H., Hu, L. T., Tao, Y., & Yang, K. (2023) · Advanced Materials · doi:10.1002/adma.202309332 · Cited by 56 · see citing works

Immunotherapy in cervix cancer

Attademo, L., Tuninetti, V., Pisano, C., Cecere, S. C., Napoli, M. D., Tambaro, R., Valabrega, G., Musacchio, L., Setola, S. V., Piccirillo, P., et al. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102088 · Cited by 52 · see citing works

Hematological toxicity in patients with solid malignant tumors treated with radiation – Temporal analysis, dose response and impact on survival

Terrones‐Campos, C., Ledergerber, B., Vogelius, I. R., Helleberg, M., Specht, L., & Lundgren, J. D. (2021) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2021.02.029 · Cited by 51 · see citing works

Grand challenges for medical physics in radiation oncology

Fiorino, C., Jeraj, R., Clark, C. H., Garibaldi, C., Georg, D., Muren, L. P., van Elmpt, W., Bortfeld, T. R., & Jornet, N. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.10.001 · Cited by 51 · see citing works

Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy

De, B. S., Ng, S. P., Liu, A. Y., Avila, S., Tao, R., Holliday, E. B., Brownlee, Z., Kaseb, A. O., Lee, S., Raghav, K. P. S., et al. (2021) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s282062 · Cited by 50 · see citing works

Human Leukocyte Antigen Class I Antigen-Processing Machinery Upregulation by Anticancer Therapies in the Era of Checkpoint Inhibitors

Sadagopan, A., Michelakos, T. P., Boyiadzis, G., Ferrone, C. R., & Ferrone, S. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.5970 · Cited by 49 · see citing works

Preclinical study and phase II trial of adapting low-dose radiotherapy to immunotherapy in small cell lung cancer

Wang, H., Yao, Z., Kang, K., Zhou, L., Xiu, W., Sun, J., Xie, C., Yu, M., Li, Y., Zhang, Y., et al. (2024) · Med · doi:10.1016/j.medj.2024.06.002 · Cited by 49 · see citing works

Enhanced radiotherapy efficacy and induced anti-tumor immunity in HCC by improving hypoxia microenvironment using oxygen microcapsules

Dai, X., Ruan, J., Guo, Y., Sun, Z., Liu, J., Bao, X., Zhang, H., Li, Q., Ye, C., Wang, X., et al. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.130109 · Cited by 49 · see citing works

Radiation therapy for extensive-stage small-cell lung cancer in the era of immunotherapy

Tian, Y., Ma, J., Jing, X., Zhai, X., Li, Y., Guo, Z., Yu, J., & Zhu, H. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215719 · Cited by 48 · see citing works

A tumor-immune interaction model for hepatocellular carcinoma based on measured lymphocyte counts in patients undergoing radiotherapy

Sung, W., Grassberger, C., McNamara, A. L., Basler, L., Ehrbar, S., Tanadini‐Lang, S., Hong, T. S., & Paganetti, H. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.07.025 · Cited by 48 · see citing works

Radiotherapy–Immunotherapy Combination: How Will We Bridge the Gap Between Pre-Clinical Promise and Effective Clinical Delivery?

Romano, E., Honeychurch, J., & Illidge, T. (2021) · Cancers · doi:10.3390/cancers13030457 · Cited by 47 · see citing works

Severe Radiation-Induced Lymphopenia Attenuates the Benefit of Durvalumab After Concurrent Chemoradiotherapy for NSCLC

Wang, J., Xu, T., Wu, L., Lopez, P. B., Grassberger, C., Ellsworth, S. G., Mohan, R., Hobbs, B. P., Blumenschein, G. R., Tu, J. C., et al. (2022) · JTO Clinical and Research Reports · doi:10.1016/j.jtocrr.2022.100391 · Cited by 47 · see citing works

Recent advances in the metal/organic hybrid nanomaterials for cancer theranostics

Ye, Z., Bao, Y., Chen, Z., Ye, H., Feng, Z., Li, Y., Zeng, Y., Pan, Z., Ouyang, D., Zhang, K., et al. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215654 · Cited by 46 · see citing works

Mathematical Modeling to Simulate the Effect of Adding Radiation Therapy to Immunotherapy and Application to Hepatocellular Carcinoma

Sung, W., Hong, T. S., Poznansky, M. C., Paganetti, H., & Grassberger, C. (2021) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2021.11.008 · Cited by 45 · see citing works

Opportunities for improving brain cancer treatment outcomes through imaging-based mathematical modeling of the delivery of radiotherapy and immunotherapy

Hormuth, D. A., Farhat, M., Christenson, C., Curl, B. J., Quarles, C. C., Chung, C. D., & Yankeelov, T. E. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114367 · Cited by 45 · see citing works

Reeducating Tumor-Associated Macrophages Using CpG@Au Nanocomposites to Modulate Immunosuppressive Microenvironment for Improved Radio-Immunotherapy

Cao, Y., Ding, S., Zeng, L., Miao, J., Wang, K., Chen, G., Li, C., Zhou, J., Bian, X., & Tian, G. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c07626 · Cited by 45 · see citing works

Is the Combination of Immunotherapy and Radiotherapy in Non-small Cell Lung Cancer a Feasible and Effective Approach?

Spaas, M., & Lievens, Y. N. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00244 · Cited by 45 · see citing works

Optimizing Radiation Therapy to Boost Systemic Immune Responses in Breast Cancer: A Critical Review for Breast Radiation Oncologists

Ho, A. Y., Wright, J. L., Blitzblau, R. C., Mutter, R. W., Duda, D. G., Norton, L., Bardia, A., Spring, L. M., Isakoff, S. J., Chen, J. H., et al. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.05.011 · Cited by 44 · see citing works

Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation

Morris, Z. S., Demaria, S., Monjazeb, A. M., Formenti, S. C., Weichselbaum, R. R., Welsh, J. D., Enderling, H., Schoenfeld, J. D., Brody, J., McGee, H. M., et al. (2025) · The Lancet Oncology · doi:10.1016/s1470-2045(24)00656-9 · Cited by 46 · see citing works

Tumor-Associated Neutrophil Extracellular Traps Regulating Nanocarrier-Enhanced Inhibition of Malignant Tumor Growth and Distant Metastasis

Yin, H., Lu, H., Xiong, Y., Ye, L., Teng, C., Cao, X., Li, S., Sun, S., Liu, W., Lv, W., et al. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c18660 · Cited by 42 · see citing works

Angiogenesis and immune checkpoint dual blockade in combination with radiotherapy for treatment of solid cancers: opportunities and challenges

Zhu, L., Yu, X., Wang, L., Liu, J., Qu, Z., Zhang, H., Li, L., Chen, J., & Zhou, Q. (2021) · Oncogenesis · doi:10.1038/s41389-021-00335-w · Cited by 43 · see citing works

Anti-TGF-β/PD-L1 bispecific antibody synergizes with radiotherapy to enhance antitumor immunity and mitigate radiation-induced pulmonary fibrosis

Wu, Y., Yan, Y., Guo, Y., Niu, M., Zhou, B., Zhang, J., Zhou, P., Chu, Q., Mei, Q., Yi, M., et al. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01678-2 · Cited by 40 · see citing works

The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific Perspectives

Wisdom, A. J., Barker, C. A., Chang, J. Y., Demaria, S., Formenti, S. C., Grassberger, C., Gregucci, F., Hoppe, B. S., Kirsch, D. G., Marciscano, A. E. E., et al. (2024) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2023.12.046 · Cited by 39 · see citing works

Single-Fraction Stereotactic Body Radiation Therapy: A Paradigm During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond?

Ng, S. S. W., Ning, M. S., Lee, P. P., McMahon, R. A., Siva, S., & Chuong, M. D. (2020) · Advances in Radiation Oncology · doi:10.1016/j.adro.2020.06.011 · Cited by 38 · see citing works

The Potentiation of Anti-Tumor Immunity by Tumor Abolition with Alpha Particles, Protons, or Carbon Ion Radiation and Its Enforcement by Combination with Immunoadjuvants or Inhibitors of Immune Suppressor Cells and Checkpoint Molecules

Keisari, Y., & Kelson, I. (2021) · Cells · doi:10.3390/cells10020228 · Cited by 37 · see citing works

Tackling the current dilemma of immunotherapy in extensive-stage small cell lung cancer: A promising strategy of combining with radiotherapy

Kang, K., Wu, Y., Yao, Z., & Lü, Y. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216239 · Cited by 38 · see citing works

Artificial intelligence in cancer research: learning at different levels of data granularity

Cirillo, D., Núñez‐Carpintero, I., & Valencia, A. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12920 · Cited by 41 · see citing works

Combining Immunotherapy with Radiation Therapy in Non–Small Cell Lung Cancer

Fitzgerald, K., & Simone, C. B. (2020) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2020.01.002 · Cited by 34 · see citing works

Tumor-Derived C-C Motif Ligand 2 Induces the Recruitment and Polarization of Tumor-Associated Macrophages and Increases the Metastatic Potential of Bladder Cancer Cells in the Postirradiated Microenvironment

Chiang, Y., Tsai, Y., Wang, C., Hsueh, F.-J., Huang, C., Chung, S., Chen, C., Pu, Y., & Cheng, J. C. (2022) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2022.06.054 · Cited by 33 · see citing works

Radio-induced lymphopenia in the era of anti-cancer immunotherapy

de Kermenguy, F., Meziani, L., Mondini, M., Clémenson, C., Morel, D., Deutsch, É., & Robert, C. (2023) · International review of cytology · doi:10.1016/bs.ircmb.2023.03.002 · Cited by 34 · see citing works

C-C chemokine receptor 4 (CCR4)-positive regulatory T cells interact with tumor-associated macrophages to facilitate metastatic potential after radiation

Chiang, Y., Lu, L.-F., Tsai, C.-L., Tsai, Y., Wang, C., Hsueh, F.-J., Huang, C., Chen, C., Pu, Y., & Cheng, J. C. (2023) · European Journal of Cancer · doi:10.1016/j.ejca.2023.113521 · Cited by 33 · see citing works

Novel strategies for tumor radiosensitization mediated by multifunctional gold-based nanomaterials

Wang, Z., Ren, X., Wang, D., Guan, L., Li, X., Zhao, Y., Liu, A., He, L., Wang, T., Zvyagin, A. V., et al. (2022) · Biomaterials Science · doi:10.1039/d2bm01496c · Cited by 33 · see citing works

Effect of Interleukin-7 on Radiation-Induced Lymphopenia and Its Antitumor Effects in a Mouse Model

Byun, H. K., Kim, K. J., Han, S. C., & Seong, J. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.12.004 · Cited by 32 · see citing works

ROS-Responsive Nanocomplex of aPD-L1 and Cabazitaxel Improves Intratumor Delivery and Potentiates Radiation-Mediated Antitumor Immunity

Wang, J., Li, J., Wu, Y., Xu, X., Qian, X., Lei, Y., Liu, H., Zhang, Z., & Li, Y. (2022) · Nano Letters · doi:10.1021/acs.nanolett.2c03227 · Cited by 31 · see citing works

Nanoparticles augment the therapeutic window of RT and immunotherapy for treating cancers: pivotal role of autophagy

Wu, Y.-H., Chen, R.-J., Chiu, H., Yang, L., Wang, Y., Chen, Y., Yeh, Y.-L., Liao, M., & Wang, Y. (2022) · Theranostics · doi:10.7150/thno.77233 · Cited by 31 · see citing works

Nanointegrative In Situ Reprogramming of Tumor-Intrinsic Lipid Droplet Biogenesis for Low-Dose Radiation-Activated Ferroptosis Immunotherapy

Zhang, Q., Wang, X., Zhao, Y., Cheng, Z., Fang, D., Liu, Y., Tian, G., Li, M., & Luo, Z. Y. (2023) · ACS Nano · doi:10.1021/acsnano.3c08907 · Cited by 30 · see citing works

Beyond success: unveiling the hidden potential of radiotherapy and immunotherapy in solid tumors

Wu, Y., Yi, M., Niu, M., Zhou, B., Mei, Q., & Wu, K. (2024) · 癌症：英文版 · doi:10.1002/cac2.12576 · Cited by 29 · see citing works

Primary lung tumour stereotactic body radiotherapy followed by concurrent mediastinal chemoradiotherapy and adjuvant immunotherapy for locally advanced non-small-cell lung cancer: a multicentre, single-arm, phase 2 trial

Heinzerling, J. H., Mileham, K. F., Robinson, M. M., Symanowski, J. T., Induru, R. R., Brouse, G., Corso, C. D., Prabhu, R. S., Haggstrom, D. E., Moeller, B. J., et al. (2024) · The Lancet Oncology · doi:10.1016/s1470-2045(24)00573-4 · Cited by 30 · see citing works

Progress of immune checkpoint inhibitors therapy for non-small cell lung cancer with liver metastases

Qu, F., Zhou, Y., & Wu, S. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02482-w · Cited by 29 · see citing works

Tumor-immune ecosystem dynamics define an individual Radiation Immune Score to predict pan-cancer radiocurability

Alfonso, J. C. L., Grass, G. D., Welsh, E. A., Ahmed, K. A., Teer, J. K., Pilon‐Thomas, S., Harrison, L. B., Cleveland, J. L., Mulé, J. J., Eschrich, S. A., et al. (2021) · Neoplasia · doi:10.1016/j.neo.2021.09.003 · Cited by 29 · see citing works

Radiation dose, schedule, and novel systemic targets for radio-immunotherapy combinations

Karapetyan, L., Iheagwara, U. K., Olson, A. C., Chmura, S. J., Skinner, H. K., & Luke, J. J. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad118 · Cited by 28 · see citing works

Radiotherapy for non-small cell lung cancer in the immunotherapy era: the opportunity and challenge—a narrative review

Xia, W.-Y., Feng, W., Zhang, C., Shen, Y., Zhang, Q., Yu, W. J., Cai, X., & Fu, X. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-827 · Cited by 29 · see citing works

Combination of bacterial-targeted delivery of gold-based AIEgen radiosensitizer for fluorescence-image-guided enhanced radio-immunotherapy against advanced cancer

Duo, Y., Chen, Z., Li, Z., Li, X., Yao, Y., Xu, T., Gao, G., & Luo, G. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.05.010 · Cited by 28 · see citing works

Metformin: (future) best friend of the radiation oncologist?

Chevalier, B., Pasquier, D., Lartigau, E. F., Chargari, C., Schernberg, A., Jannin, A., Mirabel, X., Vantyghem, M., & Escande, A. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.06.030 · Cited by 27 · see citing works

Biogenic platinum nanoparticles on bacterial fragments for enhanced radiotherapy to boost antitumor immunity

Deng, Z., Liu, J., Xi, M., Wang, C., Fang, H., Wu, X., Zhang, C., Sun, G., Zhang, Y., Shen, L., et al. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101656 · Cited by 27 · see citing works

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Chemoradiotherapy Versus Chemoradiotherapy Alone in Muscle-invasive Bladder Cancer: The MK-3475-992/KEYNOTE-992 Trial

Tissot, G., & Xylinas, E. N. (2023) · European Urology Focus · doi:10.1016/j.euf.2022.12.012 · Cited by 26 · see citing works

Prognostic value of interim CT-based peritumoral and intratumoral radiomics in laryngeal and hypopharyngeal cancer patients undergoing definitive radiotherapy

Lin, C.-H., Yan, J., Yap, W., Kang, C., Chang, Y., Tsai, T., Chang, K., Liao, C., Hsu, C., Chou, W., et al. (2023) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2023.109938 · Cited by 25 · see citing works

Novel Radiation Therapy Paradigms and Immunomodulation: Heresies and Hope

Dutt, S., Ahmed, M. M., Loo, B. W., & Strober, S. (2020) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2019.12.006 · Cited by 25 · see citing works

Microvesicle-inspired oxygen-delivering nanosystem potentiates radiotherapy-mediated modulation of tumor stroma and antitumor immunity

Gong, X., Li, J., Xu, X., Wu, Y., Lei, Y., Liu, H., Qian, X., Li, Y., & Zhang, Z. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121855 · Cited by 25 · see citing works

High proportion of circulating CD8 + CD28- senescent T cells is an independent predictor of distant metastasis in nasopharyngeal carcinoma after radiotherapy

Xu, X., Wei, F., Xiao, L., Wu, R., Wei, B., Huang, S., Yi, J., & Cui, W. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03912-2 · Cited by 25 · see citing works

An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival

Mannavola, F., Mandalà, M., Todisco, A., Chiarion‐Sileni, V., Palla, M., Minisini, A. M., Pala, L., Morgese, F., Guardo, L. D., Stucci, L. S., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01652 · Cited by 24 · see citing works

Sintilimab, stereotactic body radiotherapy and granulocyte–macrophage colony stimulating factor as second-line therapy for advanced non-small cell lung cancer: safety run-in results of a multicenter, single-arm, phase II trial

Ni, J., Zhou, Y., Wu, L., Ai, X., Dong, X., Chu, Q., Han, C., Wang, X., & Zhu, Z. (2021) · Radiation Oncology · doi:10.1186/s13014-021-01905-3 · Cited by 24 · see citing works

Transcriptional Dynamics of DNA Damage Responsive Genes in Circulating Leukocytes during Radiotherapy

Cruz-Garcia, L., Nasser, F., O’Brien, G., Grepl, J., Vinnikov, V. A., Starenkiy, V., Artiukh, S. V., Gramatiuk, S. M., & Badie, C. (2022) · Cancers · doi:10.3390/cancers14112649 · Cited by 25 · see citing works

BCG invokes superior STING ‐mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancer

Lombardo, K. A., Obradović, A., Singh, A. K., Liu, J. L., Joice, G. A., Kates, M. R., Bishai, W. R., McConkey, D. J., Chaux, A., Eich, M., et al. (2021) · The Journal of Pathology · doi:10.1002/path.5830 · Cited by 23 · see citing works

Lymphocyte Depletion Rate as a Biomarker of Radiation Dose to Circulating Lymphocytes During Fractionated Partial-Body Radiation Therapy

Ellsworth, S. G., Yalamanchali, A., Lautenschlaeger, T., Grossman, S. A., Grassberger, C., Lin, S. H., & Mohan, R. (2022) · Advances in Radiation Oncology · doi:10.1016/j.adro.2022.100959 · Cited by 23 · see citing works

A T‐Cell Inspired Sonoporation System Enhances Low‐Dose X‐Ray‐Mediated Pyroptosis and Radioimmunotherapy Efficacy by Restoring Gasdermin‐E Expression

Yin, H., Hu, X., Xie, C., Li, Y., Gao, Y., Zeng, H., Zhu, W., Xie, D., & Wang, Q. (2024) · Advanced Materials · doi:10.1002/adma.202401384 · Cited by 22 · see citing works

Chemoradiotherapy Versus Chemotherapy Alone for Advanced Esophageal Squamous Cell Carcinoma: The Role of Definitive Radiotherapy for Primary Tumor in the Metastatic Setting

Li, L., Fu, Q., Zhao, W., Wang, Y., Meng, W.-W., & Su, T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.824206 · Cited by 22 · see citing works

Betulinic acid triggers apoptosis and inhibits migration and invasion of gastric cancer cells by impairing EMT progress

Chen, Y., Wu, X., Liu, C., & Zhou, Y. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3537 · Cited by 22 · see citing works

Enzyme-responsive micellar JQ1 induces enhanced BET protein inhibition and immunotherapy of malignant tumors

Zhang, Z., Zhang, Q., Xie, J., Zhong, Z., & Deng, C. (2021) · Biomaterials Science · doi:10.1039/d1bm00724f · Cited by 22 · see citing works

Catalytic nanotechnology of X-ray photodynamics for cancer treatments

Zhang, G., Guo, M., Ma, H., Wang, J., & Zhang, X. (2022) · Biomaterials Science · doi:10.1039/d2bm01698b · Cited by 20 · see citing works

The Change of Soluble Programmed Cell Death-Ligand 1 in Glioma Patients Receiving Radiotherapy and Its Impact on Clinical Outcomes

Ding, X., Wang, L., Zhu, Y., Li, Y., Nie, S.-L., Yang, J., Liang, H. L., Weichselbaum, R. R., Yu, J., & Hu, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.580335 · Cited by 20 · see citing works

The role of radiotherapy in the age of immunotherapy

Sato, H., Demaria, S., & Ohno, T. (2020) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyaa268 · Cited by 48 · see citing works

Radiotherapy, immunity, and immune checkpoint inhibitors

Lynch, C. M., Pitroda, S. P., & Weichselbaum, R. R. (2024) · The Lancet Oncology · doi:10.1016/s1470-2045(24)00075-5 · Cited by 205 · see citing works

Understanding the Effects of Radiotherapy on the Tumour Immune Microenvironment to Identify Potential Prognostic and Predictive Biomarkers of Radiotherapy Response

Cheng, S., Cheadle, E. J., & Illidge, T. (2020) · Cancers · doi:10.3390/cancers12102835 · Cited by 16 · see citing works

Combining radiotherapy with immunotherapy: the past, the present and the future

Limbergen, E. J. V., Ruysscher, D. D., Pimentel, V. O., Marcus, D., Berbée, M., Hoeben, A., Rekers, N. H., Theys, J., Yaromina, A., Dubois, L. J., et al. (2017) · British Journal of Radiology · doi:10.1259/bjr.20170157 · Cited by 105 · see citing works

Radiotherapy and immunotherapy: a synergistic effect in cancer care

Turgeon, G., Weickhardt, A. J., Azad, A., Solomon, B., & Siva, S. (2018) · The Medical Journal of Australia · doi:10.5694/mja2.12046 · Cited by 89 · see citing works